{
    "clinical_study": {
        "@rank": "105985", 
        "arm_group": [
            {
                "arm_group_label": "Sage tablets", 
                "arm_group_type": "Experimental", 
                "description": "Sage extract, 3400 mg , DER 1:17, in once daily application over 12 weeks treatment phase"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo,  matching  the verum in size and appearance, in once daily application over   12 weeks  treatment phase"
            }
        ], 
        "brief_summary": {
            "textblock": "Sage tablets ( 3400 mg extract from fresh sage leaves, DER 1:17)  in a once daily\n      application over 12 treatment weeks are compared against placebo in 200 menopausal patients\n      with \u2265 5 hot flushes daily and a Hyperhidrosis Scale score \u2265 2"
        }, 
        "brief_title": "Efficacy and Safety of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Menopausal Hot Flushes", 
        "condition_browse": {
            "mesh_term": [
                "Flushing", 
                "Hot Flashes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Menopausal since \u2265 1 year\n\n          -  \u2265 5 hot flushes /24 hours\n\n          -  Hyperhidrosis Scale score \u2265 2\n\n        Exclusion Criteria:\n\n          -  Affections like asthma, COPD, depression, diabetes, epilepsy, hyper- and\n             hypothyreosis, malign tumours"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02032862", 
            "org_study_id": "920157"
        }, 
        "intervention": {
            "arm_group_label": "Sage tablets", 
            "intervention_name": "Sage extract, 3400 mg , DER 1:17", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "menopause, hot flushes, hot flashes, salvia, sage, sweating", 
        "lastchanged_date": "January 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Saint Gallen", 
                    "country": "Switzerland", 
                    "state": "St. Gall", 
                    "zip": "9000"
                }, 
                "name": "Dr. M. Morger"
            }, 
            "investigator": {
                "last_name": "Martin Morger, Dr. med.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Multicentric, Randomized, Double Blind Study for Assessment of Efficacy and Tolerability of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating", 
        "overall_contact": {
            "email": "s.bommer@bioforce.ch", 
            "last_name": "Silvia Bommer, Dr. med.", 
            "phone": "0041 7145", 
            "phone_ext": "46204"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from Baseline Hyperhidrosis Disease Severity Scale", 
            "safety_issue": "No", 
            "time_frame": "Week 12"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02032862"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from Baseline Menopause Rating Scale / MRS", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Change from Baseline Modified Dem Tect", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }
        ], 
        "source": "Bioforce AG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bioforce AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}